Adjuvant High-Dose Interferon for Cutaneous Melanoma is Most Beneficial for Patients with Early Stage III Disease

BACKGROUND: Evidence from randomized trials in the pre-sentinel node biopsy era indicate that adjuvant treatment with high-dose interferon-α (IFN) increases relapse-free survival (RFS) in patients with high-risk melanoma. However, the role of this treatment in selected patients with early stage III...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Anaya, Daniel A., Xing, Yan, Feng, Lei, Huang, Xuelin, Camacho, Luis H., Ross, Merrick I., Gershenwald, Jeffrey E., Lee, Jeffrey E., Mansfield, Paul F., Cormier, Janice N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4207058/
https://ncbi.nlm.nih.gov/pubmed/18320602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23399
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados